METHOTRIMEPRAZINE-2 2 MG
METHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) : 2 MG · DIN 02239632 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is METHOTRIMEPRAZINE-2?
METHOTRIMEPRAZINE-2 2 MG contains METHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02239632, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Jul-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02239632 |
|---|---|
| Brand name | METHOTRIMEPRAZINE-2 |
| Generic / active ingredient | METHOTRIMEPRAZINE (METHOTRIMEPRAZINE MALEATE) : 2 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AA02 LEVOMEPROMAZINE |
| AHFS class | 28:16.08.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Jul-2009 |
| Original market date | 1999-05-10 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05AA02 LEVOMEPROMAZINE. 5 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| METHOPRAZINE | 2 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02238403 |
| METHOPRAZINE | 25 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02238405 |
| METHOPRAZINE | 5 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02238404 |
| METHOPRAZINE | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02238406 |
| NOZINAN | 25 MG | SOLUTION | NEURAXPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 01927698 |
| METHOTRIMEPRAZINE-25 | 25 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02239634 |
| METHOTRIMEPRAZINE-5 | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02239633 |
| METHOTRIMEPRAZINE-50 | 50 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02239635 |
| NOV MEPRAZINE TAB 50MG | 50 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 01964933 |
| NOVO MEPRAZINE TAB 25MG | 25 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 01964925 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.